Subsequently, metallothionein-1 M (MT1M), which was previously identified as a tumor suppressor [111], is targeted by miR-545-3p and is thus downregulated in ESCC tissues and cells, leading to resistance to cisplatin [112]. This evidence concerns the gene MT1M and neoplasm.